The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on ...

Among inpatients at an academic center, serial adjunctive ketamine infusions were no more effective at treating major depression than midazolam, according to a randomized clinical trial published in ...

Ozark Center has opened a new site providing treatments for patients with depression who are resistant to traditional therapies. Data so far indicate the new treatments are making a difference locally ...

The J&J antipsychotic drug Caplyta won FDA approval for depression, a broader indication that could help the medicine become ...

Depression is one of the most widespread mental health disorders worldwide, characterized by persistent feelings of sadness, a loss of interest in everyday activities, dysregulated sleep or eating ...

Depression is one of the most widespread health conditions in the world. According to the World Health Organization, it affects more than 280 million people globally, cutting across age, gender, and ...

Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...

Sun Pharmaceutical issued a voluntary recall of lisdexamfetamine dimesylate capsules, used for attention ...

Gardening offers a sensory, rhythmic way to calm the nervous system, lift mood, and retrain the brain, helping us heal anxiety and depression from the ground up.